The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy — the TABANETOC trial: study protocol for a randomized clinical multicenter trial

Study Title: The TABANETOC Trial

Objective: Evaluating the Anti-Neoplastic Effects of Tinzaparin in EOC Patients

Background: Tinzaparin, a low-molecular weight heparin (LMWH), has demonstrated anti-neoplastic properties in animal models and in vitro studies of human cancer cell lines. Reduction in CA-125 levels during neoadjuvant chemotherapy (NACT) in patients with epithelial ovarian cancer (EOC) is associated with a better prognosis.

Purpose: Investigate changes in serum CA-125 levels in advanced EOC patients receiving NACT to evaluate the potential anti-neoplastic effects of tinzaparin.

Method: Open randomized multicenter pilot trial with 40 EOC patients receiving NACT randomized 1:1 to receive daily tinzaparin or no tinzaparin. Biomarkers, including CA-125, will be measured before every cycle of chemotherapy, preoperatively, and 3 weeks after the last cycle of chemotherapy.

Patients: Inclusion criteria: women aged 18 years or older, WHO performance status 0-1, histologically confirmed high-grade serous, endometrioid or clear cell EOC, FIGO stages III-IV, and CA-125 level of ≥ 250 kIE/L at diagnosis. Exclusion criteria: contraindications to LMWH, ongoing or recent treatment with specific anticoagulants.

Interpretation: This study will contribute to understanding the anti-neoplastic effects of tinzaparin in EOC patients and may guide future research on the impact of tinzaparin on survival in EOC.

Value of Clinical Trials in Healthcare

Clinical trials are essential for developing safe and effective treatments and translating their benefits into everyday medical practice. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians.

Practical Solutions for Healthcare Operations

In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.

Enhancing Workflows with AI

By utilizing AI, clinics can improve workflows, enhance patient outcomes, and reduce paper-based routines. Learn more about how we can help at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.